ASH 2021 Conference Coverage on VuMedi
P

ASH 2021 Final Results of a Phase 2 Study of Sotatercept for Anemia of MPN-Associated Myelofibrosis

By ASH 2021 Conference Coverage on VuMedi FEATURING Prithviraj Bose
By ASH 2021 Conference Coverage on VuMedi FEATURING Prithviraj Bose
88 views
December 20, 2021
0 Comments
Login to view comments. Click here to Login

Featured Video

24:35
Indy Hematology Review

Current Approaches in the Treatment of Myeloproliferative Neoplasms

Feat. A. Tefferi

Featured Video

24:44
Indy Hematology Review

State of the Art in 2024: Emerging Therapies in Hematologic Malignan…

Feat. R. Birhiray

Related Content

AUTOPLAY
23:34
Insights from 2023 ASH Annual Meeting

ASH 2023 Insights: "IV Iron Formulations - History, Safety and …

Feat. M. Auerbach
61:16
Scripps Health

Anemia: Beyond Iron Deficiency!

Feat. A. Goodman
24:08
Indy Hematology Review

Evaluation, Diagnosis, Prognostication, and Emerging Therapies for M…

Feat. A. Tefferi
27:37
Indy Hematology Review

Review of Myeloproliferative Neoplasms

Feat. A. Tefferi
18:04
Ruben Mesa

Momelotinib for Myelofibrosis: Top 10 Things You Should Know Post-FD…

17:07
Evidence-Based Hair

Iron Supplementation for Iron Deficiency Anemia

Feat. J. Donovan
30:23
Scripps MD Anderson Cancer Center Clinical Hematology & Oncology 2023

Hereditary Hemorrhagic Telangiectasia: 2023 Update

Feat. R. Kasthuri
15:14
Icahn School of Medicine at Mount Sinai

Safety Profile of Ruxolitinib in Patients With MF

Feat. D. Tremblay
05:20
Insights from 2023 ASH Annual Meeting

ASH 2023 Insights: "Symptomatic Iron Deficiency Without Anemia …

Feat. M. Sevgi
21:52
Insights from 2023 ASH Annual Meeting

ASH 2023 Summary: "MF, ET, and PV - Highlights and Clinical Imp…

Feat. D. Tremblay
10:02
Insights from 2023 ASH Annual Meeting

ASH 2023 Summary: "The Best of MPNs - Highlights & Key Take…

Feat. R. Mesa
31:43
Indy Hematology Review

Myelofibrosis: Chronic and Blast Phase - 2023 Algorithms for Risk St…

Feat. A. Tefferi
09:27
ASH 2022 Conference Coverage

MAJIC-PV Trial: Ruxolitinib vs. Best Available Therapy for PV Intole…

Feat. M. McMullin
12:18
Fred Hutchinson Cancer Center

Management of MPNs for the Community Oncologist

Feat. H. Deeg
24:53
Steven Fein

Identifying and Treating Iron Deficiency in Pregnancy

24:48
Indy Hematology Review

2024 Updates on Myelofibrosis and Systemic Mastocytosis

Feat. R. Rampal
06:51
Insights from 2023 ASH Annual Meeting

ASH 2023 Insights: "Prevalence and Prediction of Ruxolitinib Tr…

Feat. D. Tremblay
16:25
Northwestern Medicine Oncology and Hematology

Diagnosis and Goals of Therapy in PV

Feat. B. Stein
12:07
Douglas Tremblay

Monitoring Patients With MF: When to Switch Treatment

18:42
Memorial Sloan Kettering Cancer Center

Key Updates in AML, MDS, & MF From ASH

Feat. A. Goldberg